• TJP3 Drives Immune Evasion and Chemoresistance in Breast Can

  2026-05-28

  This study systematically analyzes the roles of anoikis-related genes (ARGs) in breast cancer, identifying TJP3 as a key driver of chemoresistance and immune escape. Using integrative machine learning and multi-cohort validation, the work uncovers clinically relevant subtypes and proposes ARG-based stratification as a tool for prognosis and therapy guidance.

• Biotin-XX Tyramide Reagent: Precision Cell Surface Labeling

  2026-05-27

  Biotin-XX Tyramide Reagent elevates cell surface protein labeling by delivering high-sensitivity, membrane-impermeant signal amplification. Discover how its unique structure streamlines workflow specificity and reproducibility for immunohistochemistry and in situ hybridization, transforming low-abundance target detection.

• Exosomal SNORD52 Drives M2 Polarization via JAK2/STAT6 in HC

  2026-05-27

  This study demonstrates that hepatoma cell-derived exosomal SNORD52 promotes M2 macrophage polarization by activating the JAK2/STAT6 pathway. The findings uncover a novel mechanism of tumor immune modulation in hepatocellular carcinoma, informing future strategies for targeting the tumor microenvironment.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit: Workflow & I

  2026-05-26

  The HyperScribe T7 High Yield Cy3 RNA Labeling Kit accelerates fluorescent RNA probe synthesis for in situ hybridization and Northern blotting. Its optimized T7 RNA polymerase workflow, tunable Cy3-UTP incorporation, and robust troubleshooting support set new standards for sensitivity and flexibility in molecular detection applications.

• Deep Learning Reveals Cardiotoxicity Using iPSC-Derived Mode

  2026-05-26

  This study demonstrates a robust deep learning platform for early detection of drug-induced cardiotoxicity using high-content imaging of iPSC-derived cardiomyocytes. The approach enables scalable, phenotypic screening of compound libraries, informing safer drug development and advancing cardiac electrophysiology research.

• Rhodamine B as a Quantitative Tracer in Environmental and Ce

  2026-05-25

  Rhodamine B (Basic Violet 10) offers unmatched versatility as both a quantitative tracer for pesticide drift studies and a reliable fluorescent probe for cellular imaging. Drawing on recent comparative UAV/EKS drift research, this article delivers actionable workflow guidance, troubleshooting strategies, and data-backed protocol enhancements for maximizing reproducibility in advanced fluorescence-based applications.

• One-step TUNEL Cy3 Apoptosis Detection Kit: Optimizing TdT L

  2026-05-25

  The One-step TUNEL Cy3 Apoptosis Detection Kit streamlines high-sensitivity apoptosis detection using terminal deoxynucleotidyl transferase (TdT) labeling, with robust performance across tissue sections and cultured cells. This guide details advanced workflows, troubleshooting, and insights from recent cancer research to empower precise, reproducible DNA fragmentation assays.

• Pickering Multiple Emulsions Advance mRNA Cancer Vaccine Del

  2026-05-24

  This thesis introduces a multi-level Pickering emulsion system for efficient delivery of protein and mRNA cancer vaccines, achieving superior antigen presentation and dendritic cell targeting. The approach demonstrates enhanced tumor suppression and biosafety, offering a promising alternative to conventional lipid nanoparticle methods.

• Buffer Optimization Stabilizes RNA LNPs for Nebulized Delive

  2026-05-23

  This study presents a generalizable buffer-based approach to stabilize RNA-loaded lipid nanoparticles (LNPs) during nebulization, a key challenge for pulmonary RNA therapeutics. By systematically evaluating buffer composition, the authors demonstrate improved RNA retention, particle integrity, and bioactivity, laying the groundwork for efficient inhalable mRNA and siRNA therapies.

• Macrophage-Targeted mRNA-LNPs Enhance SCI Recovery in Mice

  2026-05-22

  Fu et al. demonstrate that macrophage-targeted delivery of Mms6 mRNA via lipid nanoparticles significantly promotes locomotor recovery after traumatic spinal cord injury (SCI) in mice. By enabling endogenous macrophages to resist ferroptosis and enhance repair, this strategy offers a promising therapeutic direction for SCI and highlights advances in targeted mRNA delivery technologies.

• Lyso-Tracker Red: Precision Lysosome Labeling in Live Cells

  2026-05-22

  Lyso-Tracker Red (SKU B8814) from APExBIO enables high-specificity, live-cell lysosome labeling, facilitating advanced workflows in immunology, oncology, and nanovaccine research. Its robust fluorescence, superior selectivity, and protocol flexibility empower researchers to resolve lysosomal dynamics with clarity that legacy dyes cannot match.

• ZCL278: Selective Cdc42 Inhibitor for Cell Motility & Fibros

  2026-05-21

  ZCL278 stands out as a selective Cdc42 inhibitor, enabling researchers to dissect cell motility, neuronal branching, and fibrosis pathways with high specificity. This guide details experimental workflows, troubleshooting strategies, and the practical impact of targeting Cdc42 signaling in advanced disease models.

• Polymeric Vectors for Stable and Efficient mRNA Delivery: Th

  2026-05-21

  Shi et al. introduce a rational '4Q' design framework for polymeric mRNA delivery vectors, optimizing for room-temperature storage, in vivo stability, and efficient release. Their new polycatechol vector demonstrates superior mRNA delivery and fluorescence expression, offering a significant advance for gene expression and imaging studies.

• Thermal Shift Assays for Ligand Identification in Bacterial

  2026-05-20

  This review highlights how thermal shift assays enable systematic identification of ligands for bacterial sensor proteins, clarifying mechanisms of microbial signaling. The approach's reliability, limitations, and methodological best practices are discussed, supporting its adoption in pathway analysis and drug discovery.

• Doxorubicin: Mechanism, Benchmarks, and Modern Research Use

  2026-05-20

  Doxorubicin (Adriamycin) is a validated DNA topoisomerase II inhibitor used as a chemotherapeutic agent for solid tumors and hematologic malignancies. Its mechanism centers on DNA intercalation, leading to apoptosis induction in cancer cells. This article presents atomic, evidence-backed facts and protocol parameters for research applications.

561 records 10/38 page Previous Next First page 上5页 678910 下5页 Last page